295 related articles for article (PubMed ID: 31761617)
21. Rich1 negatively regulates the epithelial cell cycle, proliferation and adhesion by CDC42/RAC1-PAK1-Erk1/2 pathway.
Zhang J; Wang J; Zhou YF; Ren XY; Lin MM; Zhang QQ; Wang YH; Li X
Cell Signal; 2015 Sep; 27(9):1703-12. PubMed ID: 26004135
[TBL] [Abstract][Full Text] [Related]
22. NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.
Ma H; Li T; Tao Z; Hai L; Tong L; Yi L; Abeysekera IR; Liu P; Xie Y; Li J; Yuan F; Zhang C; Yang Y; Ming H; Yu S; Yang X
J Cell Physiol; 2019 Feb; 234(2):1630-1642. PubMed ID: 30159893
[TBL] [Abstract][Full Text] [Related]
23. The novel GINS4 axis promotes gastric cancer growth and progression by activating Rac1 and CDC42.
Zhu Z; Yu Z; Rong Z; Luo Z; Zhang J; Qiu Z; Huang C
Theranostics; 2019; 9(26):8294-8311. PubMed ID: 31754397
[No Abstract] [Full Text] [Related]
24. RIT1 controls actin dynamics via complex formation with RAC1/CDC42 and PAK1.
Meyer Zum Büschenfelde U; Brandenstein LI; von Elsner L; Flato K; Holling T; Zenker M; Rosenberger G; Kutsche K
PLoS Genet; 2018 May; 14(5):e1007370. PubMed ID: 29734338
[TBL] [Abstract][Full Text] [Related]
25. ARHGEF10L contributes to liver tumorigenesis through RhoA-ROCK1 signaling and the epithelial-mesenchymal transition.
Tang J; Liu C; Xu B; Wang D; Ma Z; Chang X
Exp Cell Res; 2019 Jan; 374(1):46-68. PubMed ID: 30444969
[TBL] [Abstract][Full Text] [Related]
26. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.
Guo Y; Kenney SR; Muller CY; Adams S; Rutledge T; Romero E; Murray-Krezan C; Prekeris R; Sklar LA; Hudson LG; Wandinger-Ness A
Mol Cancer Ther; 2015 Oct; 14(10):2215-27. PubMed ID: 26206334
[TBL] [Abstract][Full Text] [Related]
27. Rac1/PAK1 signaling promotes epithelial-mesenchymal transition of podocytes in vitro via triggering β-catenin transcriptional activity under high glucose conditions.
Lv Z; Hu M; Zhen J; Lin J; Wang Q; Wang R
Int J Biochem Cell Biol; 2013 Feb; 45(2):255-64. PubMed ID: 23153508
[TBL] [Abstract][Full Text] [Related]
28. POTEE promotes colorectal carcinoma progression via activating the Rac1/Cdc42 pathway.
Xu Q; Chen J; Peng M; Duan S; Hu Y; Guo D; Geng J; Zhou J
Exp Cell Res; 2020 May; 390(1):111933. PubMed ID: 32142855
[TBL] [Abstract][Full Text] [Related]
29. The Shank family of postsynaptic density proteins interacts with and promotes synaptic accumulation of the beta PIX guanine nucleotide exchange factor for Rac1 and Cdc42.
Park E; Na M; Choi J; Kim S; Lee JR; Yoon J; Park D; Sheng M; Kim E
J Biol Chem; 2003 May; 278(21):19220-9. PubMed ID: 12626503
[TBL] [Abstract][Full Text] [Related]
30. Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma.
Dasgupta A; Sierra L; Tsang SV; Kurenbekova L; Patel T; Rajapakse K; Shuck RL; Rainusso N; Landesman Y; Unger T; Coarfa C; Yustein JT
Cancer Res; 2021 Jan; 81(1):199-212. PubMed ID: 33168646
[TBL] [Abstract][Full Text] [Related]
31. Pak1 kinase homodimers are autoinhibited in trans and dissociated upon activation by Cdc42 and Rac1.
Parrini MC; Lei M; Harrison SC; Mayer BJ
Mol Cell; 2002 Jan; 9(1):73-83. PubMed ID: 11804587
[TBL] [Abstract][Full Text] [Related]
32. Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity.
Zins K; Gunawardhana S; Lucas T; Abraham D; Aharinejad S
J Transl Med; 2013 Nov; 11():295. PubMed ID: 24279335
[TBL] [Abstract][Full Text] [Related]
33. miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma.
Satterfield L; Shuck R; Kurenbekova L; Allen-Rhoades W; Edwards D; Huang S; Rajapakshe K; Coarfa C; Donehower LA; Yustein JT
Int J Cancer; 2017 Nov; 141(10):2062-2075. PubMed ID: 28748534
[TBL] [Abstract][Full Text] [Related]
34. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
Boissier P; Huynh-Do U
Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
[TBL] [Abstract][Full Text] [Related]
35. Rho GTPases RhoA and Rac1 mediate effects of dietary folate on metastatic potential of A549 cancer cells through the control of cofilin phosphorylation.
Oleinik NV; Helke KL; Kistner-Griffin E; Krupenko NI; Krupenko SA
J Biol Chem; 2014 Sep; 289(38):26383-26394. PubMed ID: 25086046
[TBL] [Abstract][Full Text] [Related]
36. Analysis of small GTPase signaling pathways using p21-activated kinase mutants that selectively couple to Cdc42.
Reeder MK; Serebriiskii IG; Golemis EA; Chernoff J
J Biol Chem; 2001 Nov; 276(44):40606-13. PubMed ID: 11514549
[TBL] [Abstract][Full Text] [Related]
37. GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis.
Chang JS; Su CY; Yu WH; Lee WJ; Liu YP; Lai TC; Jan YH; Yang YF; Shen CN; Shew JY; Lu J; Yang CJ; Huang MS; Lu PJ; Lin YF; Kuo ML; Hua KT; Hsiao M
Oncotarget; 2015 Nov; 6(34):36278-91. PubMed ID: 26462147
[TBL] [Abstract][Full Text] [Related]
38. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
39. Cdc42 and Rac1 activity is reduced in human pheochromocytoma and correlates with FARP1 and ARHGEF1 expression.
Croisé P; Houy S; Gand M; Lanoix J; Calco V; Tóth P; Brunaud L; Lomazzi S; Paramithiotis E; Chelsky D; Ory S; Gasman S
Endocr Relat Cancer; 2016 Apr; 23(4):281-93. PubMed ID: 26911374
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-874 functions as a tumor suppressor in rhabdomyosarcoma by directly targeting GEFT.
Shang H; Liu Y; Li Z; Liu Q; Cui W; Zhang L; Pang Y; Liu C; Li F
Am J Cancer Res; 2019; 9(4):668-681. PubMed ID: 31105995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
